Literature DB >> 12354015

An improved method for the synthesis of dissymmetric N,N'-disubstituted imidazole-4,5-dicarboxamides.

Alexander V Wiznycia1, Paul W Baures.   

Abstract

Symmetrically and dissymmetrically disubstituted imidazole-4,5-dicarboxamides (I45DCs) have diverse bioactivities and therefore represent useful small molecules for lead structure identification in drug discovery. For this reason, an improved synthesis was developed as a first step in the preparation of greater numbers of analogues. The method involves the transformation of imidazole-4,5-dicarboxylic acid into dissymmetrically disubstituted I45DCs in four steps and in a minimum yield of 51%. This reflects an overall reduction of one synthetic step and a greater than 30% improvement in yield over the known method.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354015     DOI: 10.1021/jo025536c

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  5 in total

1.  Parallel synthesis of an oligomeric imidazole-4,5-dicarboxamide library.

Authors:  Zhigang Xu; John C DiCesare; Paul W Baures
Journal:  J Comb Chem       Date:  2010-03-08

2.  Developing imidazoles as CEST MRI pH sensors.

Authors:  Xing Yang; Xiaolei Song; Sangeeta Ray Banerjee; Yuguo Li; Youngjoo Byun; Guanshu Liu; Zaver M Bhujwalla; Martin G Pomper; Michael T McMahon
Journal:  Contrast Media Mol Imaging       Date:  2016-04-13       Impact factor: 3.161

3.  Parallel synthesis of an imidazole-4,5-dicarboxamide library bearing amino acid esters and alkanamines.

Authors:  Rosanna Solinas; John C DiCesare; Paul W Baures
Journal:  Molecules       Date:  2008-12-15       Impact factor: 4.411

4.  Parallel synthesis of a library of symmetrically- and dissymmetrically-disubstituted imidazole-4,5-dicarboxamides bearing amino acid esters.

Authors:  Rosanna Solinas; John C DiCesare; Paul W Baures
Journal:  Molecules       Date:  2009-01-13       Impact factor: 4.411

5.  Synthesis and evaluation of imidazole-4,5- and pyrazine-2,3-dicarboxamides targeting dengue and yellow fever virus.

Authors:  Milind Saudi; Joanna Zmurko; Suzanne Kaptein; Jef Rozenski; Johan Neyts; Arthur Van Aerschot
Journal:  Eur J Med Chem       Date:  2014-09-22       Impact factor: 6.514

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.